دورية أكاديمية
Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis.
| العنوان: | Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis. |
|---|---|
| المؤلفون: | Simarro PP; World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland. simarrop@who.int., Cecchi G, Franco JR, Paone M, Diarra A, Ruiz-Postigo JA, Mattioli RC, Jannin JG |
| المصدر: | International journal of health geographics [Int J Health Geogr] 2014 Feb 11; Vol. 13, pp. 4. Date of Electronic Publication: 2014 Feb 11. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101152198 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-072X (Electronic) Linking ISSN: 1476072X NLM ISO Abbreviation: Int J Health Geogr Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BioMed Central, [2002]- |
| مواضيع طبية MeSH: | Geographic Mapping* , Trypanosoma brucei gambiense*/isolation & purification, Geographic Information Systems/*trends , Health Facilities/*trends , Health Services Accessibility/*trends , Trypanosomiasis, African/*epidemiology , Trypanosomiasis, African/*therapy, Africa/epidemiology ; Health Facilities/standards ; Health Services Accessibility/standards ; Humans ; Population Surveillance/methods ; Risk Factors ; Trypanosomiasis, African/diagnosis |
| مستخلص: | Background: The emphasis placed on the activities of mobile teams in the detection of gambiense human African trypanosomiasis (HAT) can at times obscure the major role played by fixed health facilities in HAT control and surveillance. The lack of consistent and detailed data on the coverage of passive case-finding and treatment further constrains our ability to appreciate the full contribution of the health system to the control of HAT. Methods: A survey was made of all fixed health facilities that are active in the control and surveillance of gambiense HAT. Information on their diagnostic and treatment capabilities was collected, reviewed and harmonized. Health facilities were geo-referenced. Time-cost distance analysis was conducted to estimate physical accessibility and the potential coverage of the population at-risk of gambiense HAT. Results: Information provided by the National Sleeping Sickness Control Programmes revealed the existence of 632 fixed health facilities that are active in the control and surveillance of gambiense HAT in endemic countries having reported cases or having conducted active screening activities during the period 2000-2012. Different types of diagnosis (clinical, serological, parasitological and disease staging) are available from 622 facilities. Treatment with pentamidine for first-stage disease is provided by 495 health facilities, while for second-stage disease various types of treatment are available in 206 health facilities only. Over 80% of the population at-risk for gambiense HAT lives within 5-hour travel of a fixed health facility offering diagnosis and treatment for the disease. Conclusions: Fixed health facilities have played a crucial role in the diagnosis, treatment and coverage of at-risk-population for gambiense HAT. As the number of reported cases continues to dwindle, their role will become increasingly important for the prospects of disease elimination. Future updates of the database here presented will regularly provide evidence to inform and monitor a rational deployment of control and surveillance efforts. Support to the development and, if successful, the implementation of new control tools (e.g. new diagnostics and new drugs) is crucial, both for strengthening and expanding the existing network of fixed health facilities by improving access to diagnosis and treatment and for securing a sustainable control and surveillance of gambiense HAT. |
| References: | PLoS Negl Trop Dis. 2008;2(12):e303. (PMID: 19104656) N Engl J Med. 2013 Mar 14;368(11):1069-70. (PMID: 23484849) Parasite. 2009 Jun;16(2):99-106. (PMID: 19585887) Int J Health Geogr. 2010 Nov 01;9:57. (PMID: 21040555) Trop Med Int Health. 2011 Jul;16(7):869-74. (PMID: 21447063) World Health Organ Tech Rep Ser. 2013;(984):1-237. (PMID: 24552089) PLoS Med. 2008 Feb;5(2):e55. (PMID: 18303943) Int J Health Geogr. 2009 Mar 18;8:15. (PMID: 19296837) AIDS. 2012 Nov 28;26(18):2351-60. (PMID: 22951637) Bull World Health Organ. 2013 Oct 1;91(10):718. (PMID: 24115791) PLoS Negl Trop Dis. 2012;6(10):e1859. (PMID: 23145192) PLoS Negl Trop Dis. 2010 Dec 21;4(12):e923. (PMID: 21200426) Med Trop (Mars). 2007 Oct;67(5):447-57. (PMID: 18225727) Ann Soc Belg Med Trop. 1978;58(3):169-76. (PMID: 747425) Int J Health Geogr. 2012 Mar 20;11:7. (PMID: 22433126) Emerg Infect Dis. 2011 Dec;17(12):2322-4. (PMID: 22172322) BMC Pregnancy Childbirth. 2009 Aug 11;9:34. (PMID: 19671156) PLoS Negl Trop Dis. 2013 Oct 17;7(10):e2504. (PMID: 24147176) PLoS Negl Trop Dis. 2011 Jun;5(6):e1151. (PMID: 21738803) Wkly Epidemiol Rec. 2006 Feb 24;81(8):71-80. (PMID: 16673459) Popul Health Metr. 2011 Feb 07;9:4. (PMID: 21299885) J Travel Med. 2012 Jan-Feb;19(1):44-53. (PMID: 22221811) PLoS Negl Trop Dis. 2012 Jan;6(1):e1467. (PMID: 22272367) |
| معلومات مُعتمدة: | 001 International WHO_ World Health Organization |
| تواريخ الأحداث: | Date Created: 20140213 Date Completed: 20141018 Latest Revision: 20220408 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC3938140 |
| DOI: | 10.1186/1476-072X-13-4 |
| PMID: | 24517513 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1476-072X |
|---|---|
| DOI: | 10.1186/1476-072X-13-4 |